tiprankstipranks
Advertisement
Advertisement

PCCEPHE Stock Latest News

Cepheid Study Shows Xpert Xpress MVP Sharply Improves Vaginitis Treatment Decisions
Private CompaniesCepheid Study Shows Xpert Xpress MVP Sharply Improves Vaginitis Treatment Decisions
4h ago
CEPHE
Cepheid Emphasizes Stewardship-Focused Diagnostics and Global Health Engagement in Active Week
PremiumPrivate Companies
Cepheid Emphasizes Stewardship-Focused Diagnostics and Global Health Engagement in Active Week
3d ago
CEPHE
Diagnostics Reframing Positioned as Tool in Antimicrobial Resistance Fight
PremiumPrivate Companies
Diagnostics Reframing Positioned as Tool in Antimicrobial Resistance Fight
4d ago
CEPHE
Cepheid Highlights Clinically Focused GI Diagnostics Strategy
PremiumPrivate Companies
Cepheid Highlights Clinically Focused GI Diagnostics Strategy
5d ago
CEPHE
Focus on Group B Strep Diagnostics Highlights Strategic Healthcare Niche
PremiumPrivate Companies
Focus on Group B Strep Diagnostics Highlights Strategic Healthcare Niche
6d ago
CEPHE
Danaher Showcases Integrated Diagnostics Portfolio With Cepheid at ADLM 2026
PremiumPrivate CompaniesDanaher Showcases Integrated Diagnostics Portfolio With Cepheid at ADLM 2026
6d ago
CEPHE
Strategic Focus on Drug-Resistant Tuberculosis Diagnostics Signals Growth Opportunities
Premium
Private Companies
Strategic Focus on Drug-Resistant Tuberculosis Diagnostics Signals Growth Opportunities
8d ago
CEPHE
Danaher-Linked Cepheid Highlighted in $1 Million Ebola Response Effort
Premium
Private Companies
Danaher-Linked Cepheid Highlighted in $1 Million Ebola Response Effort
8d ago
CEPHE
Cepheid – Weekly Recap
PremiumPrivate Companies
Cepheid – Weekly Recap
10d ago
CEPHE
Cepheid Highlights Growing Need for Advanced C. diff Diagnostics
PremiumPrivate Companies
Cepheid Highlights Growing Need for Advanced C. diff Diagnostics
11d ago
CEPHE
Cepheid to Showcase Diagnostics Capabilities at ADLM 2026
PremiumPrivate Companies
Cepheid to Showcase Diagnostics Capabilities at ADLM 2026
12d ago
CEPHE
Educational Initiative Underscores Cepheid’s Focus on Respiratory Diagnostics
PremiumPrivate Companies
Educational Initiative Underscores Cepheid’s Focus on Respiratory Diagnostics
12d ago
CEPHE
Respiratory Diagnostics Webinar Underscores Cepheid’s Focus on Clinical Education
PremiumPrivate CompaniesRespiratory Diagnostics Webinar Underscores Cepheid’s Focus on Clinical Education
13d ago
CEPHE
Cepheid – Weekly Recap
Premium
Private Companies
Cepheid – Weekly Recap
17d ago
CEPHE
Pediatric Antimicrobial Resistance Spotlight Underscores Diagnostic Testing Demand
Premium
Private Companies
Pediatric Antimicrobial Resistance Spotlight Underscores Diagnostic Testing Demand
18d ago
CEPHE
Webinar Initiative Highlights Cepheid’s Focus on Syndromic GI Diagnostic Stewardship
PremiumPrivate Companies
Webinar Initiative Highlights Cepheid’s Focus on Syndromic GI Diagnostic Stewardship
19d ago
CEPHE
Pipeline Activity in Respiratory Diagnostics at Cepheid
PremiumPrivate Companies
Pipeline Activity in Respiratory Diagnostics at Cepheid
20d ago
CEPHE
Cepheid Backs Educational Webinar on Respiratory Molecular Diagnostics
PremiumPrivate Companies
Cepheid Backs Educational Webinar on Respiratory Molecular Diagnostics
20d ago
CEPHE
Cepheid Highlights Rapid Multiplex Vaginal Diagnostic Panel
PremiumPrivate Companies
Cepheid Highlights Rapid Multiplex Vaginal Diagnostic Panel
21d ago
CEPHE
Cepheid Showcases Rapid PCR Capabilities at FIDSSA Infectious-Disease Congress
PremiumPrivate CompaniesCepheid Showcases Rapid PCR Capabilities at FIDSSA Infectious-Disease Congress
22d ago
CEPHE
Cepheid Strengthens AMR Strategy and Outbreak Role While Advancing Respiratory Pipeline
Premium
Private Companies
Cepheid Strengthens AMR Strategy and Outbreak Role While Advancing Respiratory Pipeline
24d ago
CEPHE
Molecular Screening Adoption Highlights Demand Potential for Cepheid Diagnostics
Premium
Private Companies
Molecular Screening Adoption Highlights Demand Potential for Cepheid Diagnostics
25d ago
CEPHE

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >